$136.44
0.15%
NYSE, Mar 28, 09:10 pm CET
ISIN
US14149Y1082
Symbol
CAH

Cardinal Health Stock price

$136.44
+6.96 5.38% 1M
+25.92 23.45% 6M
+18.17 15.36% YTD
+24.54 21.93% 1Y
+78.64 136.06% 3Y
+88.00 181.67% 5Y
+45.64 50.26% 10Y
NYSE, Closing price Fri, Mar 28 2025
-0.21 0.15%
ISIN
US14149Y1082
Symbol
CAH
Sector

Key metrics

Market capitalization $32.96b
Enterprise Value $36.83b
P/E (TTM) P/E ratio 25.47
EV/FCF (TTM) EV/FCF negative
EV/Sales (TTM) EV/Sales 0.17
P/S ratio (TTM) P/S ratio 0.15
P/B ratio (TTM) P/B ratio negative
Dividend yield 1.48%
Last dividend (FY25) $2.02
Revenue growth (TTM) Revenue growth 2.85%
Revenue (TTM) Revenue $222.32b
EBIT (operating result TTM) EBIT $2.26b
Free Cash Flow (TTM) Free Cash Flow $-513.00m
Cash position $3.81b
EPS (TTM) EPS $5.36
P/E forward 19.70
P/S forward 0.15
EV/Sales forward 0.17
Short interest 3.61%
Show more

Is Cardinal Health a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,804 stocks worldwide.

Cardinal Health Stock Analysis

Unlock Scores for Free

Analyst Opinions

19 Analysts have issued a Cardinal Health forecast:

13x Buy
68%
5x Hold
26%
1x Sell
5%

Analyst Opinions

19 Analysts have issued a Cardinal Health forecast:

Buy
68%
Hold
26%
Sell
5%

Financial data from Cardinal Health

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Dec '24
+/-
%
222,319 222,319
3% 3%
100%
- Direct Costs 214,921 214,921
3% 3%
97%
7,398 7,398
5% 5%
3%
- Selling and Administrative Expenses 4,405 4,405
4% 4%
2%
- Research and Development Expense - -
-
-
2,993 2,993
7% 7%
1%
- Depreciation and Amortization 737 737
6% 6%
0%
EBIT (Operating Income) EBIT 2,256 2,256
7% 7%
1%
Net Profit 1,309 1,309
105% 105%
1%

In millions USD.

Don't miss a Thing! We will send you all news about Cardinal Health directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Cardinal Health Stock News

Neutral
PRNewsWire
6 days ago
DUBLIN, Ohio , March 25, 2025 /PRNewswire/ -- Cardinal Health (NYSE: CAH) plans to release third-quarter financial results for its fiscal year 2025 on May 1, prior to the opening of trading on the New York Stock Exchange. The company will webcast a discussion of these results beginning at 8:30 a.m.
Neutral
Seeking Alpha
18 days ago
Cardinal Health, Inc. (NYSE:CAH ) Leerink's 2025 Global Healthcare Conference Call March 12, 2025 8:40 AM ET Company Participants Aaron Alt - Chief Financial Officer Matt Sims - Investor Relations Conference Call Participants Mike Cherny - Leerink Mike Cherny Perfect. We'll get started here.
Neutral
PRNewsWire
21 days ago
DUBLIN, Ohio , March 10, 2025 /PRNewswire/ -- Cardinal Health (NYSE:CAH) announced today that its Board of Directors has elected Robert Musslewhite, former Chief Executive Officer of Definitive Healthcare Corp., and Sudhakar Ramakrishna, President and Chief Executive Officer of SolarWinds Corporation, as independent directors, effective March 7, 2025. With more than 20 years of leadership exper...
More Cardinal Health News

Company Profile

Cardinal Health, Inc. is a healthcare services and products company, which engages in the provision of customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories and physician offices. It also provides medical products and pharmaceuticals and cost-effective solutions that enhance supply chain efficiency. The company operates through the following segments: Pharmaceutical and Medical. The Pharmaceutical segment distributes branded and generic pharmaceutical, specialty pharmaceutical and over-the-counter healthcare and consumer products. The Medical segment manufactures, sources and distributes cardinal health branded medical, surgical and laboratory products. The company was founded by Robert D. Walter in 1979 and is headquartered in Dublin, OH.

Head office United States
CEO Jason Hollar
Employees 48,900
Founded 1979
Website www.cardinalhealth.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today